Helen B. Forrester,^1,2,3,* Pavel N. Lobachevsky,^4,5,6 Andrew W. Stevenson,^7,8 Christopher J. Hall,⁷ Olga A. Martin,^9,5,** Carl N. Sprung<sup>1,2,**

1</sup>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia
²Monash University, Clayton, Australia
³School of Science, RMIT University, Melbourne, Australia
⁴Research Division
⁵Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
⁶Advanced Analytical Technologies, Melbourne, Australia
⁷Australian Synchrotron, ANSTO, Clayton, Australia
⁸CSIRO Manufacturing, Clayton, Australia
⁹Research Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

^* Address for correspondence: School of Science, RMIT University, 124 La Trobe Street, Melbourne, Victoria, 3000 Australia; email: helen.forrester@rmit.edu.au.
^** These authors contributed equally to this work.